Kezar Life Sciences
41 hedge funds and large institutions have $21.1M invested in Kezar Life Sciences in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
25% less capital invested
Capital invested by funds: $28.2M → $21.1M (-$7.11M)
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Holders
41
Holding in Top 10
1
Calls
$58K
Puts
$1K
Top Buyers
| 1 | +$1.75M | |
| 2 | +$200K | |
| 3 | +$125K | |
| 4 |
Squarepoint
New York
|
+$99.1K |
| 5 |
CHAM
Clear Harbor Asset Management
Stamford,
Connecticut
|
+$77.1K |
Top Sellers
| 1 | -$956K | |
| 2 | -$174K | |
| 3 | -$147K | |
| 4 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$120K |
| 5 |
Goldman Sachs
New York
|
-$118K |
